Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study

Clostridium difficile is a major cause of nosocomial diarrhea. The incidence and prognosis of C. difficile‐associated diarrhea (CDAD) has not yet been assessed in adult patients after unrelated cord blood transplantation (uCBT).

[1]  H. Greinix,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease , 2015 .

[2]  Daniel Wolff,et al.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  Christy A. Varughese,et al.  Antibiotic-Associated Diarrhea , 2013, Journal of pharmacy practice.

[4]  Y. Kanda,et al.  Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.

[5]  R. Owens.  Clostridium difficile-Associated Disease , 2012, Drugs.

[6]  R. Porcher,et al.  Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  M. Kami,et al.  Allogeneic cord blood transplantation for adult acute lymphoblastic leukemia: retrospective survey involving 256 patients in Japan , 2012, Leukemia.

[8]  G. Alangaden,et al.  Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation , 2011, Clinical transplantation.

[9]  Y. Arakawa,et al.  Typing of Clostridium difficile isolates endemic in Japan by sequencing of slpA and its application to direct typing. , 2010, Journal of medical microbiology.

[10]  D. Gerding,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.

[11]  J. Dipersio,et al.  Clostridium difficile‐associated disease in allogeneic hematopoietic stem‐cell transplant recipients: risk associations, protective associations, and outcomes , 2010, Clinical transplantation.

[12]  B. Currie,et al.  Incidence of Clostridium difficile Infection in Patients with Acute Leukemia and Lymphoma after Allogeneic Hematopoietic Stem Cell Transplantation , 2010, Infection Control & Hospital Epidemiology.

[13]  H. Einsele,et al.  Life-Threatening Infection Caused by Daptomycin-Resistant Corynebacterium jeikeium in a Neutropenic Patient , 2009, Journal of Clinical Microbiology.

[14]  B. Sandmaier,et al.  Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[15]  M. Remberger,et al.  Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor , 2008, Bone Marrow Transplantation.

[16]  H. Lazarus,et al.  Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? , 2008, Bone Marrow Transplantation.

[17]  T. Sugihara,et al.  Successful treatment of meningoencephalitis caused by methicillin-resistant Staphylococcus aureus with intravenous linezolid in an allogeneic cord blood stem cell transplant recipient , 2008, Scandinavian journal of infectious diseases.

[18]  C. Kelly,et al.  Update on Clostridium difficile associated disease , 2007, Current opinion in gastroenterology.

[19]  R. Owens.  Clostridium difficile-associated disease: changing epidemiology and implications for management. , 2007, Drugs.

[20]  Chao‐Ping Yang,et al.  Fulminant septicaemia caused by multi-drug-resistant Streptococcus mitis following unrelated cord blood transplantation , 2006, Annals of tropical paediatrics.

[21]  J. Sierra,et al.  Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[22]  Y. Kanda,et al.  Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  M. Turner,et al.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  S. Pillai,et al.  Linezolid-Resistant Enterococcus faecalis Isolated from a Cord Blood Transplant Recipient , 2004, Journal of Clinical Microbiology.

[25]  G. Sanz,et al.  Unrelated donor umbilical cord blood transplantation in adults , 2002, Leukemia.

[26]  T. Calandra,et al.  Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer , 2002 .

[27]  J. Winter,et al.  Rarity of toxigenic Clostridium difficile infections after hematopoietic stem cell transplantation: implications for symptomatic management of diarrhea , 2002, Bone Marrow Transplantation.

[28]  D. Milligan,et al.  Clostridium difficile infection in allogeneic stem cell transplant recipients is associated with severe graft-versus-host disease and non-relapse mortality , 2000, Bone Marrow Transplantation.

[29]  D. Gerding,et al.  Is there a relationship between vancomycin-resistant enterococcal infection and Clostridium difficile infection? , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  J. Klein,et al.  IBMTR Severity INDEX FOR GRADING ACUTE GRAFT‐VERSUS‐HOST DISEASE: RETROSPECTIVE COMPARISON WITH GLUCKSBERG GRADE , 1997, British journal of haematology.

[31]  C. Surawicz,et al.  Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  W. Graninger,et al.  Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  A. Glatt,et al.  Clostridium difficile infection associated with antineoplastic chemotherapy: a review. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  D. Gerding,et al.  PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS , 1983, The Lancet.

[35]  B. Greene,et al.  12 MONTH FOLLOW-UP OF MEBENDAZOLE THERAPY FOR ONCHOCERCIASIS , 1981, The Lancet.